Skip to content
NovoSeven
| Product Specs |
NovoSeven |
| Manufacturer Name |
Novo Nordisk |
| Indications |
Treatment of bleeding episodes and perioperative management in adults and children with hemophilia A or B with inhibitors, congenital Factor VII (FVII) deficiency, and Glanzmann’s thrombasthenia with refractoriness to platelet transfusions, with or without antibodies to platelets.
Treatment of bleeding episodes and perioperative management in adults with acquired hemophilia
|
| Contraindications |
None known |
| Viral Safety Process |
Chromatography |
| Product Half-Life |
Healthy subjects: 3.54 (0.28) hours |
| Manufacturing Method |
Recombinant |
| Storage Requirements/Shelf Life |
Prior to reconstitution, store powder and histidine diluent between 2 – 25°C (36-77°F).
Do not freeze.
Store protected from light.
Do not use past the expiration date.
After reconstitution, store either at room temperature or refrigerated for up to 3 hours
Do not freeze reconstituted solution or store in syringes.
|
| Nominal Vial Size & Diluent Volume |
1 mg /1 mL L-histidine in water
2 mg /2 mL L-histidine in water
5 mg /5 mL L-histidine in water
8 mg /8 mL L-histidine in water |
Return to Manufacturer Name listing Return to Factor Type listing
